Report ID: SQMIG35A2279
Report ID:
SQMIG35A2279 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
59 |
Figures:
75
In October 2023, IQVIA™, a prominent global provider of cutting-edge analytics, technology solutions, and clinical research services to the life sciences industry, uncovered a strategic partnership with Argenx. This collaboration plans to upgrade treatment for patients with rare autoimmune diseases using innovative and integrated technology-enabled pharmacovigilance (PV) safety services and solutions.
In September 2023, Mayo Clinic and GE Healthcare unveiled a strategic healthcare collaboration. Their partnership focuses on research and product development drives intended to revolutionize the patient and clinician experience in radiology practice and the administration of innovative treatments.
In September 2023, Atropos Health, famous for its evidence-based healthcare innovations like the Green Button Clinical Informatics Consult Service, disclosed the completion of a strategic financing round. This funding was obtained from investors including Presidio Ventures (the venture arm of Sumitomo Corporation Venture Group), Samsung Next (a venture arm of Samsung Electronics), Gaingels, Audere Capital, and other contributors. With this financial backing, Atropos Health aims to assist commercial and developmental endeavors beyond the U.S., using its exclusive technology and technique. The initial focus will be on serving key customers in Japan and Brazil.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2279